Iobenguane I-124 is an experimental radiopharmaceutical used for positron emission tomography (PET/CT) imaging to detect neuroendocrine tumors, including neuroblastoma, pheochromocytoma, and paraganglioma. It functions as a PET tracer that accumulates in sympathetic nervous system tumors, offering higher resolution imaging. Its therapeutic use is listed as diagnostic agents. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include m-Iodobenzylguanidine-124I and 124I-metaiodobenzylguanidine. Its PubChem CID is 9838355.
Iobenguane I-124
| CAS No | 119159-02-3 |
|---|---|
| Molecular Formula | C8H10IN3 |
| Molecular Weight | 272.09 g/mol |
| Synonyms | 2-[(3-(124I)iodophenyl)methyl]guanidine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Iobenguane I-124 is an experimental radiopharmaceutical used for positron emission tomography (PET/CT) imaging to detect neuroendocrine tumors, including neuroblastoma, pheochromocytoma, and paraganglioma.
The listed CAS number is 119159-02-3.
The listed molecular formula is C8H10IN3.
The listed molecular weight is 272.09 g/mol.
2-[(3-(124I)iodophenyl)methyl]guanidine.
The source lists m-Iodobenzylguanidine-124I and 124I-metaiodobenzylguanidine.